Icaritin opposes the development of social aversion after defeat stress via increases of GR mRNA and BDNF mRNA in mice

Behavioural Brain Research

Volumn 256, Issue , 2013, Pages 602-608

  Wu, Xiao ^a   Wu, Jinfeng ^a   Xia, Shijin ^b   Li, Bei ^a   Dong, Jingcheng ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

BDNF; Depression; GR; HPA axis; Icaritin

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; ICARIIN; ICARITIN; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG STRUCTURE; HIPPOCAMPUS; HORMONE RESISTANCE; HORMONE SENSITIVITY; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOCIAL AVERSION; SOCIAL DEFEAT; SOCIAL STRESS;

BDNF; DEPRESSION; GR; HPA AXIS; ICARITIN;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; FLAVONOIDS; HYPOTHALAMUS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SOCIAL DOMINANCE; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884788094     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.09.034     Document Type: Article

References (34)

1. Murray C.J., Lopez A.D. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996, 274:740-743.
2. Phillips L.J., McGorry P.D., Garner B., Thompson K.N., Pantelis C., Wood S.J., et al. Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. The Australian and New Zealand Journal of Psychiatry 2006, 40:725-741.
3. Grigoriadis D.E. The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders. Expert Opinion on Therapeutic Targets 2005, 9:651-684.
4. Pariante C.M. Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Annals of the New York Academy of Sciences 2009, 1179:144-152.
5. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends in Neurosciences 2008, 31:464-468.
6. Juruena M.F., Cleare A.J., Papadopoulos A.S., Poon L., Lightman S., Pariante C.M. Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology 2006, 189:225-235.
7. Carvalho L.A., Juruena M.F., Papadopoulos A.S., Poon L., Kerwin R., Cleare A.J., et al. Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2008, 33:3182-3189.
8. Carvalho L.A., Pariante C.M. In vitro modulation of the glucocorticoid receptor by antidepressants. Stress 2008, 11:411-424.
9. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain, Behavior, and Immunity 2007, 21:9-19.
10. Miller A.H., Pariante C.M., Pearce B.D. Effects of cytokines on glucocorticoid receptor expression and function glucocorticoid resistance and relevance to depression. Advances in Experimental Medicine and Biology 1999, 461:107-116.
11. Wang X., Wu H., Miller A.H. Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function. Molecular Psychiatry 2004, 9:65-75.
12. Pan Y., Zhang W.Y., Xia X., Kong L.D. Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley rats. Biological & Pharmaceutical Bulletin 2006, 29:2399-2403.
13. Pan Y., Kong L.D., Li Y.C., Xia X., Kung H.F., Jiang F.X. Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacology, Biochemistry, and Behavior 2007, 87:130-140.
14. Pan Y., Wang F.M., Qiang L.Q., Zhang D.M., Kong L.D. Icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats. Psychoneuroendocrinology 2010, 35:272-283.
15. Qian Q., Li S.L., Sun E., Zhang K.R., Tan X.B., Wei Y.J., et al. Metabolite profiles of icariin in rat plasma by ultra-fast liquid chromatography coupled to triple-quadrupole/time-of-flight mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2012, 66:392-398.
16. Wang Z., Zhang X., Wang H., Qi L., Lou Y. Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway. Neuroscience 2007, 145:911-922.
17. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
18. Stark J.L., Avitsur R., Hunzeker J., Padgett D.A., Sheridan J.F. Interleukin-6 and the development of social disruption-induced glucocorticoid resistance. Journal of Neuroimmunology 2002, 124:9-15.
19. Savignac H.M., Hyland N.P., Dinan T.G., Cryan J.F. The effects of repeated social interaction stress on behavioural and physiological parameters in a stress-sensitive mouse strain. Behavioural Brain Research 2011, 216:576-584.
20. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
21. Lowy M.T., Reder A.T., Antel J.P., Meltzer H.Y. Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone. The American Journal of Psychiatry 1984, 141:1365-1370.
22. Wodarz N., Rupprecht R., Kornhuber J., Schmitz B., Wild K., Braner H.U., et al. Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression. Journal of Affective Disorders 1991, 22:241-248.
23. Tanke M.A., Bosker F.J., Gladkevich A.V., Medema H.M., den Boer J.A., Korf J. Lymphocyte glucocorticoid receptor resistance and depressive symptoms severity: a preliminary report. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008, 32:1298-1301.
24. Anacker C., Zunszain P.A., Carvalho L.A., Pariante C.M. The glucocorticoid receptor: pivot of depression and of antidepressant treatment. Psychoneuroendocrinology 2011, 36:415-425.
25. Heiske A., Jesberg J., Krieg J.C., Vedder H. Differential effects of antidepressants on glucocorticoid receptors in human primary blood cells and human monocytic U-937 cells. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2003, 28:807-817.
26. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annual Review of Neuroscience 2001, 24:677-736.
27. De Foubert G., Carney S.L., Robinson C.S., Destexhe E.J., Tomlinson R., Hicks C.A., et al. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 2004, 128:597-604.
28. Castren E., Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Developmental Neurobiology 2010, 70:289-297.
29. Schmidt H.D., Duman R.S. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2010, 35:2378-2391.
30. Thompson Ray M., Weickert C.S., Wyatt E., Webster M.J. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. Journal of Psychiatry & Neuroscience: Jpn 2011, 36:195-203.
31. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 2006, 27:24-31.
32. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009, 65:732-741.
33. Zunszain P.A., Anacker C., Cattaneo A., Carvalho L.A., Pariante C.M. Glucocorticoids, cytokines and brain abnormalities in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011, 35:722-729.
34. Lai X., Ye Y., Sun C., Huang X., Tang X., Zeng X., et al. Icaritin exhibits anti-inflammatory effects in the mouse peritoneal macrophages and peritonitis model. International Immunopharmacology 2013, 16:41-49.